nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—Pulmonary eosinophilia—Ramipril—type 1 diabetes mellitus	0.0215	0.0667	CcSEcCtD
Mesalazine—MPO—saliva—type 1 diabetes mellitus	0.0189	0.177	CbGeAlD
Mesalazine—Alopecia reversible—Ramipril—type 1 diabetes mellitus	0.0173	0.0537	CcSEcCtD
Mesalazine—Red blood cell sedimentation rate increased—Ramipril—type 1 diabetes mellitus	0.0146	0.0453	CcSEcCtD
Mesalazine—Olsalazine—IFNG—type 1 diabetes mellitus	0.00811	0.589	CrCbGaD
Mesalazine—CHUK—cardiovascular system—type 1 diabetes mellitus	0.00801	0.0747	CbGeAlD
Mesalazine—Hepatic necrosis—Ramipril—type 1 diabetes mellitus	0.00676	0.021	CcSEcCtD
Mesalazine—CHUK—lymphoid tissue—type 1 diabetes mellitus	0.00673	0.0628	CbGeAlD
Mesalazine—Psoriasis—Ramipril—type 1 diabetes mellitus	0.00625	0.0194	CcSEcCtD
Mesalazine—ALOX5—islet of Langerhans—type 1 diabetes mellitus	0.00624	0.0582	CbGeAlD
Mesalazine—Parosmia—Ramipril—type 1 diabetes mellitus	0.00605	0.0188	CcSEcCtD
Mesalazine—Bone marrow depression—Ramipril—type 1 diabetes mellitus	0.00582	0.0181	CcSEcCtD
Mesalazine—Burning sensation—Ramipril—type 1 diabetes mellitus	0.00565	0.0175	CcSEcCtD
Mesalazine—IKBKB—cardiovascular system—type 1 diabetes mellitus	0.00545	0.0508	CbGeAlD
Mesalazine—PPARG—islet of Langerhans—type 1 diabetes mellitus	0.00469	0.0437	CbGeAlD
Mesalazine—Liver injury—Ramipril—type 1 diabetes mellitus	0.00467	0.0145	CcSEcCtD
Mesalazine—IKBKB—lymphoid tissue—type 1 diabetes mellitus	0.00458	0.0427	CbGeAlD
Mesalazine—ALOX5—cardiovascular system—type 1 diabetes mellitus	0.00451	0.0421	CbGeAlD
Mesalazine—Jaundice cholestatic—Ramipril—type 1 diabetes mellitus	0.00447	0.0139	CcSEcCtD
Mesalazine—Proteinuria—Ramipril—type 1 diabetes mellitus	0.00447	0.0139	CcSEcCtD
Mesalazine—Protein urine present—Ramipril—type 1 diabetes mellitus	0.00441	0.0137	CcSEcCtD
Mesalazine—ALOX5—pancreas—type 1 diabetes mellitus	0.00439	0.0409	CbGeAlD
Mesalazine—Cough increased—Ramipril—type 1 diabetes mellitus	0.00429	0.0133	CcSEcCtD
Mesalazine—Leukocytosis—Ramipril—type 1 diabetes mellitus	0.00418	0.013	CcSEcCtD
Mesalazine—Hepatocellular injury—Ramipril—type 1 diabetes mellitus	0.00393	0.0122	CcSEcCtD
Mesalazine—MPO—cardiovascular system—type 1 diabetes mellitus	0.00382	0.0356	CbGeAlD
Mesalazine—ALOX5—lymphoid tissue—type 1 diabetes mellitus	0.00379	0.0354	CbGeAlD
Mesalazine—MPO—kidney—type 1 diabetes mellitus	0.00374	0.0349	CbGeAlD
Mesalazine—MPO—pancreas—type 1 diabetes mellitus	0.00371	0.0346	CbGeAlD
Mesalazine—Blood urea increased—Ramipril—type 1 diabetes mellitus	0.00371	0.0115	CcSEcCtD
Mesalazine—Neuropathy—Ramipril—type 1 diabetes mellitus	0.00369	0.0114	CcSEcCtD
Mesalazine—PPARG—cardiovascular system—type 1 diabetes mellitus	0.00339	0.0316	CbGeAlD
Mesalazine—PPARG—kidney—type 1 diabetes mellitus	0.00332	0.0309	CbGeAlD
Mesalazine—PPARG—pancreas—type 1 diabetes mellitus	0.00329	0.0307	CbGeAlD
Mesalazine—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.00325	0.0101	CcSEcCtD
Mesalazine—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.00322	0.00998	CcSEcCtD
Mesalazine—MPO—lymphoid tissue—type 1 diabetes mellitus	0.00321	0.0299	CbGeAlD
Mesalazine—Deafness—Ramipril—type 1 diabetes mellitus	0.00319	0.00989	CcSEcCtD
Mesalazine—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.00317	0.00985	CcSEcCtD
Mesalazine—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.00309	0.00958	CcSEcCtD
Mesalazine—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00307	0.00954	CcSEcCtD
Mesalazine—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.00301	0.00934	CcSEcCtD
Mesalazine—Renal impairment—Ramipril—type 1 diabetes mellitus	0.003	0.0093	CcSEcCtD
Mesalazine—Arthritis—Ramipril—type 1 diabetes mellitus	0.00293	0.0091	CcSEcCtD
Mesalazine—PPARG—lymphoid tissue—type 1 diabetes mellitus	0.00285	0.0266	CbGeAlD
Mesalazine—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.00283	0.00878	CcSEcCtD
Mesalazine—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.00267	0.00829	CcSEcCtD
Mesalazine—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00263	0.00817	CcSEcCtD
Mesalazine—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.0026	0.00808	CcSEcCtD
Mesalazine—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.0026	0.00808	CcSEcCtD
Mesalazine—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00258	0.008	CcSEcCtD
Mesalazine—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.00257	0.00797	CcSEcCtD
Mesalazine—Gastritis—Ramipril—type 1 diabetes mellitus	0.00252	0.00783	CcSEcCtD
Mesalazine—Asthma—Ramipril—type 1 diabetes mellitus	0.00246	0.00765	CcSEcCtD
Mesalazine—Influenza—Ramipril—type 1 diabetes mellitus	0.00246	0.00765	CcSEcCtD
Mesalazine—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00246	0.00765	CcSEcCtD
Mesalazine—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.00244	0.00757	CcSEcCtD
Mesalazine—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.00242	0.00752	CcSEcCtD
Mesalazine—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00242	0.0075	CcSEcCtD
Mesalazine—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.0024	0.00745	CcSEcCtD
Mesalazine—PTGS2—islet of Langerhans—type 1 diabetes mellitus	0.00239	0.0223	CbGeAlD
Mesalazine—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00237	0.00735	CcSEcCtD
Mesalazine—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00236	0.00733	CcSEcCtD
Mesalazine—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00234	0.00726	CcSEcCtD
Mesalazine—Neutropenia—Ramipril—type 1 diabetes mellitus	0.0023	0.00715	CcSEcCtD
Mesalazine—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00229	0.00711	CcSEcCtD
Mesalazine—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00225	0.00698	CcSEcCtD
Mesalazine—Weight increased—Ramipril—type 1 diabetes mellitus	0.00224	0.00696	CcSEcCtD
Mesalazine—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.00218	0.00676	CcSEcCtD
Mesalazine—Renal failure—Ramipril—type 1 diabetes mellitus	0.00216	0.0067	CcSEcCtD
Mesalazine—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.00215	0.00668	CcSEcCtD
Mesalazine—Jaundice—Ramipril—type 1 diabetes mellitus	0.00214	0.00665	CcSEcCtD
Mesalazine—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00214	0.00665	CcSEcCtD
Mesalazine—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00214	0.00663	CcSEcCtD
Mesalazine—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00214	0.00663	CcSEcCtD
Mesalazine—Sweating—Ramipril—type 1 diabetes mellitus	0.00211	0.00654	CcSEcCtD
Mesalazine—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.00208	0.00645	CcSEcCtD
Mesalazine—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00207	0.00643	CcSEcCtD
Mesalazine—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00206	0.0064	CcSEcCtD
Mesalazine—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.00205	0.00636	CcSEcCtD
Mesalazine—Droxidopa—ADRB1—type 1 diabetes mellitus	0.00199	0.145	CrCbGaD
Mesalazine—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00197	0.00612	CcSEcCtD
Mesalazine—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00194	0.00603	CcSEcCtD
Mesalazine—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.00194	0.00602	CcSEcCtD
Mesalazine—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.00186	0.00579	CcSEcCtD
Mesalazine—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00184	0.00571	CcSEcCtD
Mesalazine—PTGS1—cardiovascular system—type 1 diabetes mellitus	0.00181	0.0169	CbGeAlD
Mesalazine—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00178	0.00553	CcSEcCtD
Mesalazine—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00178	0.00552	CcSEcCtD
Mesalazine—PTGS1—kidney—type 1 diabetes mellitus	0.00177	0.0165	CbGeAlD
Mesalazine—Alopecia—Ramipril—type 1 diabetes mellitus	0.00174	0.00541	CcSEcCtD
Mesalazine—PTGS2—cardiovascular system—type 1 diabetes mellitus	0.00173	0.0162	CbGeAlD
Mesalazine—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00173	0.00536	CcSEcCtD
Mesalazine—Erythema—Ramipril—type 1 diabetes mellitus	0.00172	0.00533	CcSEcCtD
Mesalazine—PTGS2—kidney—type 1 diabetes mellitus	0.00169	0.0158	CbGeAlD
Mesalazine—Tension—Ramipril—type 1 diabetes mellitus	0.00168	0.00523	CcSEcCtD
Mesalazine—PTGS2—pancreas—type 1 diabetes mellitus	0.00168	0.0157	CbGeAlD
Mesalazine—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00168	0.00522	CcSEcCtD
Mesalazine—Nervousness—Ramipril—type 1 diabetes mellitus	0.00167	0.00518	CcSEcCtD
Mesalazine—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00165	0.00512	CcSEcCtD
Mesalazine—Tremor—Ramipril—type 1 diabetes mellitus	0.00161	0.00499	CcSEcCtD
Mesalazine—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00159	0.00494	CcSEcCtD
Mesalazine—Angioedema—Ramipril—type 1 diabetes mellitus	0.00157	0.00487	CcSEcCtD
Mesalazine—Dopamine—ADRB1—type 1 diabetes mellitus	0.00156	0.113	CrCbGaD
Mesalazine—Malaise—Ramipril—type 1 diabetes mellitus	0.00155	0.00481	CcSEcCtD
Mesalazine—Vertigo—Ramipril—type 1 diabetes mellitus	0.00154	0.00479	CcSEcCtD
Mesalazine—Syncope—Ramipril—type 1 diabetes mellitus	0.00154	0.00478	CcSEcCtD
Mesalazine—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00154	0.00477	CcSEcCtD
Mesalazine—Palpitations—Ramipril—type 1 diabetes mellitus	0.00152	0.00471	CcSEcCtD
Mesalazine—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00151	0.00468	CcSEcCtD
Mesalazine—Cough—Ramipril—type 1 diabetes mellitus	0.0015	0.00465	CcSEcCtD
Mesalazine—Chest pain—Ramipril—type 1 diabetes mellitus	0.00146	0.00454	CcSEcCtD
Mesalazine—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00146	0.00454	CcSEcCtD
Mesalazine—Myalgia—Ramipril—type 1 diabetes mellitus	0.00146	0.00454	CcSEcCtD
Mesalazine—Anxiety—Ramipril—type 1 diabetes mellitus	0.00146	0.00452	CcSEcCtD
Mesalazine—PTGS2—lymphoid tissue—type 1 diabetes mellitus	0.00146	0.0136	CbGeAlD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00145	0.00451	CcSEcCtD
Mesalazine—Discomfort—Ramipril—type 1 diabetes mellitus	0.00144	0.00448	CcSEcCtD
Mesalazine—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00143	0.00444	CcSEcCtD
Mesalazine—Confusional state—Ramipril—type 1 diabetes mellitus	0.00141	0.00438	CcSEcCtD
Mesalazine—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.0014	0.00435	CcSEcCtD
Mesalazine—Oedema—Ramipril—type 1 diabetes mellitus	0.0014	0.00435	CcSEcCtD
Mesalazine—Shock—Ramipril—type 1 diabetes mellitus	0.00138	0.00428	CcSEcCtD
Mesalazine—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00137	0.00426	CcSEcCtD
Mesalazine—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00137	0.00426	CcSEcCtD
Mesalazine—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00137	0.00424	CcSEcCtD
Mesalazine—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00136	0.00422	CcSEcCtD
Mesalazine—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00135	0.0042	CcSEcCtD
Mesalazine—Diflunisal—ALB—type 1 diabetes mellitus	0.00135	0.0982	CrCbGaD
Mesalazine—Anorexia—Ramipril—type 1 diabetes mellitus	0.00134	0.00415	CcSEcCtD
Mesalazine—Hypotension—Ramipril—type 1 diabetes mellitus	0.00131	0.00406	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00128	0.00396	CcSEcCtD
Mesalazine—Insomnia—Ramipril—type 1 diabetes mellitus	0.00127	0.00393	CcSEcCtD
Mesalazine—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00126	0.00391	CcSEcCtD
Mesalazine—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00125	0.00388	CcSEcCtD
Mesalazine—Somnolence—Ramipril—type 1 diabetes mellitus	0.00125	0.00387	CcSEcCtD
Mesalazine—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00123	0.00383	CcSEcCtD
Mesalazine—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00122	0.00378	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00121	0.00375	CcSEcCtD
Mesalazine—Fatigue—Ramipril—type 1 diabetes mellitus	0.00121	0.00375	CcSEcCtD
Mesalazine—Constipation—Ramipril—type 1 diabetes mellitus	0.0012	0.00372	CcSEcCtD
Mesalazine—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00115	0.00358	CcSEcCtD
Mesalazine—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00115	0.00356	CcSEcCtD
Mesalazine—Urticaria—Ramipril—type 1 diabetes mellitus	0.00111	0.00345	CcSEcCtD
Mesalazine—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00111	0.00344	CcSEcCtD
Mesalazine—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00111	0.00344	CcSEcCtD
Mesalazine—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00103	0.0032	CcSEcCtD
Mesalazine—Asthenia—Ramipril—type 1 diabetes mellitus	0.00101	0.00312	CcSEcCtD
Mesalazine—Pruritus—Ramipril—type 1 diabetes mellitus	0.000991	0.00308	CcSEcCtD
Mesalazine—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000959	0.00298	CcSEcCtD
Mesalazine—Dizziness—Ramipril—type 1 diabetes mellitus	0.000926	0.00288	CcSEcCtD
Mesalazine—Vomiting—Ramipril—type 1 diabetes mellitus	0.000891	0.00277	CcSEcCtD
Mesalazine—Rash—Ramipril—type 1 diabetes mellitus	0.000883	0.00274	CcSEcCtD
Mesalazine—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000883	0.00274	CcSEcCtD
Mesalazine—Headache—Ramipril—type 1 diabetes mellitus	0.000878	0.00272	CcSEcCtD
Mesalazine—Nausea—Ramipril—type 1 diabetes mellitus	0.000832	0.00258	CcSEcCtD
Mesalazine—Salicylic acid—ALB—type 1 diabetes mellitus	0.000752	0.0546	CrCbGaD
Mesalazine—CHUK—Signaling by ERBB2—IL6—type 1 diabetes mellitus	0.000123	0.000221	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—EGFR—type 1 diabetes mellitus	0.000123	0.00022	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CRP—type 1 diabetes mellitus	0.000122	0.00022	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—IL6—type 1 diabetes mellitus	0.000122	0.00022	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—HBA2—type 1 diabetes mellitus	0.000122	0.000219	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—ERBB3—type 1 diabetes mellitus	0.000121	0.000218	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—CASP3—type 1 diabetes mellitus	0.000121	0.000218	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—HLA-B—type 1 diabetes mellitus	0.000121	0.000217	CbGpPWpGaD
Mesalazine—CHUK—Disease—B2M—type 1 diabetes mellitus	0.00012	0.000216	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—CAT—type 1 diabetes mellitus	0.000119	0.000215	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ITPR3—type 1 diabetes mellitus	0.000119	0.000214	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—PTPN2—type 1 diabetes mellitus	0.000119	0.000214	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—IL6—type 1 diabetes mellitus	0.000119	0.000214	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—B2M—type 1 diabetes mellitus	0.000118	0.000212	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TNF—type 1 diabetes mellitus	0.000117	0.00021	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—ERBB3—type 1 diabetes mellitus	0.000117	0.000209	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—IL6—type 1 diabetes mellitus	0.000115	0.000207	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—IL6—type 1 diabetes mellitus	0.000115	0.000207	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—type 1 diabetes mellitus	0.000115	0.000207	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HLA-DPB1—type 1 diabetes mellitus	0.000115	0.000207	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—G6PC2—type 1 diabetes mellitus	0.000115	0.000206	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—STAT3—type 1 diabetes mellitus	0.000114	0.000205	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—IL6—type 1 diabetes mellitus	0.000114	0.000205	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HLA-E—type 1 diabetes mellitus	0.000113	0.000203	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—IL6—type 1 diabetes mellitus	0.000113	0.000203	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—HLA-DRB1—type 1 diabetes mellitus	0.000113	0.000202	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—IL6—type 1 diabetes mellitus	0.000113	0.000202	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—HBA1—type 1 diabetes mellitus	0.000112	0.000202	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000112	0.000202	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—STAT3—type 1 diabetes mellitus	0.000112	0.000202	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—HLA-A—type 1 diabetes mellitus	0.000112	0.000201	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—APOC3—type 1 diabetes mellitus	0.000112	0.000201	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000111	0.000199	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000111	0.000199	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CRP—type 1 diabetes mellitus	0.000111	0.000199	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—IL6—type 1 diabetes mellitus	0.000111	0.000199	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TYK2—type 1 diabetes mellitus	0.00011	0.000198	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GSTT1—type 1 diabetes mellitus	0.00011	0.000197	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000109	0.000196	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CTLA4—type 1 diabetes mellitus	0.000109	0.000196	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CD80—type 1 diabetes mellitus	0.000108	0.000195	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000104	0.000187	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—type 1 diabetes mellitus	0.000104	0.000187	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HLA-DPB1—type 1 diabetes mellitus	0.000104	0.000187	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD79A—type 1 diabetes mellitus	0.000104	0.000187	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD80—type 1 diabetes mellitus	0.000104	0.000187	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—STAT3—type 1 diabetes mellitus	0.000104	0.000186	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HLA-E—type 1 diabetes mellitus	0.000103	0.000184	CbGpPWpGaD
Mesalazine—CHUK—Immune System—PRKCQ—type 1 diabetes mellitus	0.000102	0.000183	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—HLA-DRB1—type 1 diabetes mellitus	0.000102	0.000183	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—EGFR—type 1 diabetes mellitus	0.000102	0.000183	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—type 1 diabetes mellitus	0.000102	0.000183	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000102	0.000183	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—STAT3—type 1 diabetes mellitus	0.000102	0.000183	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000101	0.000182	CbGpPWpGaD
Mesalazine—CHUK—Disease—NOS1—type 1 diabetes mellitus	0.000101	0.000181	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000101	0.000181	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000101	0.000181	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ABCC8—type 1 diabetes mellitus	9.95e-05	0.000179	CbGpPWpGaD
Mesalazine—CHUK—Immune System—VAV1—type 1 diabetes mellitus	9.92e-05	0.000178	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—KCNJ11—type 1 diabetes mellitus	9.91e-05	0.000178	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CTLA4—type 1 diabetes mellitus	9.89e-05	0.000178	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CD80—type 1 diabetes mellitus	9.82e-05	0.000176	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HLA-DQA1—type 1 diabetes mellitus	9.6e-05	0.000172	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CHRM2—type 1 diabetes mellitus	9.46e-05	0.00017	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD79A—type 1 diabetes mellitus	9.43e-05	0.000169	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CD80—type 1 diabetes mellitus	9.43e-05	0.000169	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—IL6—type 1 diabetes mellitus	9.43e-05	0.000169	CbGpPWpGaD
Mesalazine—CHUK—Disease—PRKCQ—type 1 diabetes mellitus	9.43e-05	0.000169	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—ITPR3—type 1 diabetes mellitus	9.37e-05	0.000168	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—PRKCQ—type 1 diabetes mellitus	9.26e-05	0.000166	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—EGFR—type 1 diabetes mellitus	9.25e-05	0.000166	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—VDR—type 1 diabetes mellitus	9.23e-05	0.000166	CbGpPWpGaD
Mesalazine—CHUK—Disease—VAV1—type 1 diabetes mellitus	9.16e-05	0.000164	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—TYK2—type 1 diabetes mellitus	9.14e-05	0.000164	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—VAV1—type 1 diabetes mellitus	8.99e-05	0.000161	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HLA-DQB1—type 1 diabetes mellitus	8.98e-05	0.000161	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SH2B3—type 1 diabetes mellitus	8.82e-05	0.000158	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—APOC3—type 1 diabetes mellitus	8.77e-05	0.000157	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IAPP—type 1 diabetes mellitus	8.77e-05	0.000157	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GCG—type 1 diabetes mellitus	8.74e-05	0.000157	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HLA-DQA1—type 1 diabetes mellitus	8.71e-05	0.000156	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD86—type 1 diabetes mellitus	8.65e-05	0.000155	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ITPR3—type 1 diabetes mellitus	8.5e-05	0.000153	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD40LG—type 1 diabetes mellitus	8.48e-05	0.000152	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD8A—type 1 diabetes mellitus	8.39e-05	0.000151	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ITPR3—type 1 diabetes mellitus	8.36e-05	0.00015	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	8.35e-05	0.00015	CbGpPWpGaD
Mesalazine—PTGS2—Disease—SLC11A1—type 1 diabetes mellitus	8.3e-05	0.000149	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—TYK2—type 1 diabetes mellitus	8.29e-05	0.000149	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CD4—type 1 diabetes mellitus	8.27e-05	0.000149	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HLA-DQB1—type 1 diabetes mellitus	8.14e-05	0.000146	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HLA-B—type 1 diabetes mellitus	8.07e-05	0.000145	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SH2B3—type 1 diabetes mellitus	8e-05	0.000144	CbGpPWpGaD
Mesalazine—CHUK—Disease—CD86—type 1 diabetes mellitus	7.98e-05	0.000143	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL6—type 1 diabetes mellitus	7.98e-05	0.000143	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	7.95e-05	0.000143	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—APOC3—type 1 diabetes mellitus	7.95e-05	0.000143	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IAPP—type 1 diabetes mellitus	7.95e-05	0.000143	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD4—type 1 diabetes mellitus	7.94e-05	0.000143	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—INS—type 1 diabetes mellitus	7.93e-05	0.000142	CbGpPWpGaD
Mesalazine—PTGS2—Disease—ITPR3—type 1 diabetes mellitus	7.93e-05	0.000142	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—HBA1—type 1 diabetes mellitus	7.87e-05	0.000141	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—KCNJ11—type 1 diabetes mellitus	7.86e-05	0.000141	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD86—type 1 diabetes mellitus	7.84e-05	0.000141	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—IL6—type 1 diabetes mellitus	7.84e-05	0.000141	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—APOC3—type 1 diabetes mellitus	7.82e-05	0.00014	CbGpPWpGaD
Mesalazine—CHUK—Immune System—ERBB3—type 1 diabetes mellitus	7.8e-05	0.00014	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—STAT3—type 1 diabetes mellitus	7.72e-05	0.000139	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SST—type 1 diabetes mellitus	7.7e-05	0.000138	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD40LG—type 1 diabetes mellitus	7.69e-05	0.000138	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GSTT1—type 1 diabetes mellitus	7.68e-05	0.000138	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—ADRB1—type 1 diabetes mellitus	7.66e-05	0.000138	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD8A—type 1 diabetes mellitus	7.6e-05	0.000137	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL2RA—type 1 diabetes mellitus	7.56e-05	0.000136	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CD4—type 1 diabetes mellitus	7.5e-05	0.000135	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HLA-A—type 1 diabetes mellitus	7.47e-05	0.000134	CbGpPWpGaD
Mesalazine—PTGS2—Disease—APOC3—type 1 diabetes mellitus	7.41e-05	0.000133	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IAPP—type 1 diabetes mellitus	7.41e-05	0.000133	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—CAT—type 1 diabetes mellitus	7.4e-05	0.000133	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HLA-B—type 1 diabetes mellitus	7.31e-05	0.000131	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—ALB—type 1 diabetes mellitus	7.27e-05	0.000131	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL6—type 1 diabetes mellitus	7.23e-05	0.00013	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CD4—type 1 diabetes mellitus	7.2e-05	0.000129	CbGpPWpGaD
Mesalazine—CHUK—Disease—ERBB3—type 1 diabetes mellitus	7.2e-05	0.000129	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CRP—type 1 diabetes mellitus	7.13e-05	0.000128	CbGpPWpGaD
Mesalazine—PTGS2—Disease—B2M—type 1 diabetes mellitus	7.12e-05	0.000128	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—IL6—type 1 diabetes mellitus	7.11e-05	0.000128	CbGpPWpGaD
Mesalazine—CHUK—Disease—CCR5—type 1 diabetes mellitus	7.08e-05	0.000127	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	7.08e-05	0.000127	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—ERBB3—type 1 diabetes mellitus	7.07e-05	0.000127	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—EGFR—type 1 diabetes mellitus	7.02e-05	0.000126	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SST—type 1 diabetes mellitus	6.98e-05	0.000125	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—NOS3—type 1 diabetes mellitus	6.96e-05	0.000125	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ADRB1—type 1 diabetes mellitus	6.95e-05	0.000125	CbGpPWpGaD
Mesalazine—CHUK—Disease—HLA-A—type 1 diabetes mellitus	6.9e-05	0.000124	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GCG—type 1 diabetes mellitus	6.86e-05	0.000123	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL2RA—type 1 diabetes mellitus	6.85e-05	0.000123	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HLA-DRB1—type 1 diabetes mellitus	6.83e-05	0.000123	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HLA-A—type 1 diabetes mellitus	6.78e-05	0.000122	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TNF—type 1 diabetes mellitus	6.68e-05	0.00012	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ITPR3—type 1 diabetes mellitus	6.64e-05	0.000119	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	6.6e-05	0.000119	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CRP—type 1 diabetes mellitus	6.47e-05	0.000116	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—VAV1—type 1 diabetes mellitus	6.41e-05	0.000115	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CXCL10—type 1 diabetes mellitus	6.39e-05	0.000115	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD80—type 1 diabetes mellitus	6.31e-05	0.000113	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—HBA1—type 1 diabetes mellitus	6.25e-05	0.000112	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GCG—type 1 diabetes mellitus	6.22e-05	0.000112	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—APOC3—type 1 diabetes mellitus	6.21e-05	0.000112	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HLA-DRB1—type 1 diabetes mellitus	6.19e-05	0.000111	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GCG—type 1 diabetes mellitus	6.12e-05	0.00011	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GSTT1—type 1 diabetes mellitus	6.1e-05	0.00011	CbGpPWpGaD
Mesalazine—CHUK—Disease—NOS2—type 1 diabetes mellitus	6e-05	0.000108	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	5.99e-05	0.000108	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NOS1—type 1 diabetes mellitus	5.96e-05	0.000107	CbGpPWpGaD
Mesalazine—CHUK—Disease—CD80—type 1 diabetes mellitus	5.82e-05	0.000105	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—EGFR—type 1 diabetes mellitus	5.82e-05	0.000104	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—VAV1—type 1 diabetes mellitus	5.81e-05	0.000104	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IGF2—type 1 diabetes mellitus	5.81e-05	0.000104	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CXCL10—type 1 diabetes mellitus	5.8e-05	0.000104	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD80—type 1 diabetes mellitus	5.72e-05	0.000103	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	5.62e-05	0.000101	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CD86—type 1 diabetes mellitus	5.59e-05	0.0001	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—EGFR—type 1 diabetes mellitus	5.59e-05	0.0001	CbGpPWpGaD
Mesalazine—PTGS2—Disease—PRKCQ—type 1 diabetes mellitus	5.58e-05	0.0001	CbGpPWpGaD
Mesalazine—CHUK—Disease—INS—type 1 diabetes mellitus	5.5e-05	9.88e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—VAV1—type 1 diabetes mellitus	5.42e-05	9.74e-05	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—IL6—type 1 diabetes mellitus	5.39e-05	9.69e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—TYK2—type 1 diabetes mellitus	5.33e-05	9.56e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.31e-05	9.53e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—EGFR—type 1 diabetes mellitus	5.28e-05	9.48e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IGF2—type 1 diabetes mellitus	5.26e-05	9.45e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CAT—type 1 diabetes mellitus	5.18e-05	9.3e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CD86—type 1 diabetes mellitus	5.07e-05	9.1e-05	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—EGFR—type 1 diabetes mellitus	5.07e-05	9.1e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.04e-05	9.05e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IFNG—type 1 diabetes mellitus	4.99e-05	8.96e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCR5—type 1 diabetes mellitus	4.96e-05	8.91e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—TYK2—type 1 diabetes mellitus	4.92e-05	8.83e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—INS—type 1 diabetes mellitus	4.91e-05	8.82e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL2RA—type 1 diabetes mellitus	4.89e-05	8.78e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GCG—type 1 diabetes mellitus	4.86e-05	8.73e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—TYK2—type 1 diabetes mellitus	4.83e-05	8.67e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—NOS3—type 1 diabetes mellitus	4.83e-05	8.67e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD4—type 1 diabetes mellitus	4.82e-05	8.65e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—E2F1—type 1 diabetes mellitus	4.81e-05	8.64e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CD86—type 1 diabetes mellitus	4.73e-05	8.49e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ERBB3—type 1 diabetes mellitus	4.57e-05	8.21e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IFNG—type 1 diabetes mellitus	4.52e-05	8.12e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ALB—type 1 diabetes mellitus	4.5e-05	8.08e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCR5—type 1 diabetes mellitus	4.5e-05	8.07e-05	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—IL6—type 1 diabetes mellitus	4.47e-05	8.03e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL1B—type 1 diabetes mellitus	4.45e-05	7.99e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—CD4—type 1 diabetes mellitus	4.45e-05	7.99e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL2RA—type 1 diabetes mellitus	4.43e-05	7.96e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL2—type 1 diabetes mellitus	4.43e-05	7.96e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD4—type 1 diabetes mellitus	4.37e-05	7.84e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—NOS3—type 1 diabetes mellitus	4.31e-05	7.73e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—ERBB3—type 1 diabetes mellitus	4.26e-05	7.66e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CCR5—type 1 diabetes mellitus	4.19e-05	7.53e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CAT—type 1 diabetes mellitus	4.11e-05	7.39e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—HLA-A—type 1 diabetes mellitus	4.09e-05	7.34e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CD80—type 1 diabetes mellitus	4.08e-05	7.32e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—IL6—type 1 diabetes mellitus	4.06e-05	7.28e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL1B—type 1 diabetes mellitus	4.03e-05	7.24e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL2—type 1 diabetes mellitus	4.02e-05	7.22e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—INS—type 1 diabetes mellitus	3.85e-05	6.92e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—STAT3—type 1 diabetes mellitus	3.73e-05	6.7e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.73e-05	6.69e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CD80—type 1 diabetes mellitus	3.7e-05	6.64e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NOS2—type 1 diabetes mellitus	3.56e-05	6.39e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—INS—type 1 diabetes mellitus	3.49e-05	6.28e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CD80—type 1 diabetes mellitus	3.45e-05	6.2e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.44e-05	6.18e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—STAT3—type 1 diabetes mellitus	3.44e-05	6.18e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—INS—type 1 diabetes mellitus	3.44e-05	6.18e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—EGFR—type 1 diabetes mellitus	3.39e-05	6.09e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—STAT3—type 1 diabetes mellitus	3.38e-05	6.07e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.38e-05	6.07e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.38e-05	6.07e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—INS—type 1 diabetes mellitus	3.26e-05	5.85e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ALB—type 1 diabetes mellitus	3.15e-05	5.66e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—EGFR—type 1 diabetes mellitus	3.13e-05	5.62e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.12e-05	5.61e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—EGFR—type 1 diabetes mellitus	3.07e-05	5.52e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.06e-05	5.5e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—NOS3—type 1 diabetes mellitus	3.02e-05	5.42e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—TYK2—type 1 diabetes mellitus	2.91e-05	5.23e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.87e-05	5.15e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL2—type 1 diabetes mellitus	2.87e-05	5.15e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NOS3—type 1 diabetes mellitus	2.86e-05	5.13e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—INS—type 1 diabetes mellitus	2.73e-05	4.9e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CD4—type 1 diabetes mellitus	2.63e-05	4.73e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL6—type 1 diabetes mellitus	2.6e-05	4.68e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.6e-05	4.67e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL2—type 1 diabetes mellitus	2.6e-05	4.67e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ALB—type 1 diabetes mellitus	2.5e-05	4.5e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.41e-05	4.33e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—IL6—type 1 diabetes mellitus	2.4e-05	4.32e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—NOS3—type 1 diabetes mellitus	2.39e-05	4.3e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL6—type 1 diabetes mellitus	2.36e-05	4.24e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.19e-05	3.94e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.19e-05	3.93e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—STAT3—type 1 diabetes mellitus	2.04e-05	3.66e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.99e-05	3.57e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—EGFR—type 1 diabetes mellitus	1.85e-05	3.33e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL6—type 1 diabetes mellitus	1.68e-05	3.02e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL6—type 1 diabetes mellitus	1.53e-05	2.74e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IL6—type 1 diabetes mellitus	1.42e-05	2.56e-05	CbGpPWpGaD
